• LAST PRICE
    1.8200
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.5525%)
  • Bid / Lots
    1.6100/ 5
  • Ask / Lots
    1.8700/ 2
  • Open / Previous Close
    1.7900 / 1.8100
  • Day Range
    Low 1.7420
    High 1.8500
  • 52 Week Range
    Low 1.4500
    High 5.5969
  • Volume
    72,280
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.81
TimeVolumeTCRX
09:32 ET19091.7528
09:33 ET1001.82
09:37 ET6481.8296
09:39 ET1001.82
09:48 ET41001.82
09:50 ET1001.82
09:51 ET34001.8202
09:53 ET3001.82
09:57 ET1001.82
10:02 ET1001.82
10:04 ET1001.82
10:09 ET3001.821
10:11 ET38001.82
10:13 ET3001.82
10:15 ET1001.83
10:18 ET1001.82
10:20 ET2001.82
10:22 ET8001.8205
10:26 ET1011.83
10:27 ET5001.82
10:29 ET8001.82
10:47 ET12001.8208
10:49 ET18481.82
11:03 ET2001.8385
11:05 ET1001.8201
11:07 ET16001.82
11:12 ET13001.75
11:14 ET1001.785
11:18 ET1001.82
11:20 ET4001.82
11:21 ET3001.82
11:23 ET1001.82
11:32 ET1001.82
11:56 ET53001.8
12:06 ET1001.82
12:08 ET8001.8202
12:10 ET2001.82
12:12 ET2001.82
12:14 ET3001.82
12:15 ET17721.82
12:32 ET13001.82
12:33 ET2001.81
12:35 ET2001.82
12:37 ET1001.82
12:39 ET1001.82
12:42 ET3001.82
12:44 ET1001.82
12:46 ET1001.82
12:48 ET1001.82
12:50 ET1001.82
12:51 ET2001.82
12:53 ET1001.81
12:55 ET3681.82
12:57 ET2001.82
01:00 ET1001.82
01:02 ET1001.81
01:04 ET3001.82
01:06 ET2001.82
01:08 ET1001.82
01:09 ET2001.82
01:11 ET1361.82
01:13 ET1001.82
01:15 ET1001.82
01:18 ET1641.82
01:20 ET1001.82
01:22 ET2001.82
01:24 ET3011.82
01:26 ET2001.82
01:27 ET1001.82
01:29 ET3001.82
01:36 ET10001.82
01:44 ET11001.83
01:47 ET8001.83
01:49 ET1001.84
02:00 ET10001.8201
02:20 ET31011.82
02:21 ET20001.83
02:34 ET11001.8209
02:43 ET50471.83
02:45 ET50001.8405
02:50 ET1001.85
03:48 ET31331.85
03:53 ET1711.85
03:55 ET31061.83
03:57 ET11751.82
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTCRX
TScan Therapeutics Inc
43.8M
-0.7x
---
United StatesOCX
OncoCyte Corp
46.3M
-0.6x
---
United StatesERYP
Erytech Pharma SA
38.6M
0.0x
---
United StatesSGTX
Sigilon Therapeutics Inc
22.8M
-0.4x
---
United StatesAVTX
Avalo Therapeutics Inc
36.6M
-0.7x
---
United StatesLPCN
Lipocine Inc
48.7M
11.8x
---
As of 2023-02-04

Company Information

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. The Company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. The Company is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. The Company has developed and continues to build its ImmunoBank, a collection of solid tumor targets across different Human leukocyte antigens (HLAs) types in the TCR field. The Company's platform discovers anti-cancer TCRs from patients with responses to immunotherapy and also manufactures TCR-T therapies. It is also advancing five solid tumor programs: TSC-200, TSC-204, TSC-201, TSC-202, and TSC-203.

Contact Information

Headquarters
880 Winter StreetWALTHAM, MA, United States 02451
Phone
857-399-9500
Fax
302-531-3150

Executives

Non-Executive Independent Chairman
Timothy Barberich
President, Chief Executive Officer, Director
David Southwell
Chief Financial Officer, Treasurer
Brian Silver
Chief Scientific and Operations Officer
Gavin Macbeath
Vice President - Finance
Leiden Dworak

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$43.8M
Revenue (TTM)
$13.3M
Shares Outstanding
24.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.58
Book Value
$6.72
P/E Ratio
-0.7x
Price/Sales (TTM)
3.3
Price/Cash Flow (TTM)
---
Operating Margin
-467.80%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.